Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04001088 · ClinicalTrials.gov registry record · Phase 2
The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health
A Phase 2 study, sponsored by Lallemand Health Solutions.
- Completed
- Registry status
- Phase 2
- Development phase
- 144
- Enrollment target
NCT04001088 is a Phase 2 study that has completed, run by Lallemand Health Solutions. The registered enrollment target is 144 participants.
The verdict
NCT04001088, a Phase 2 study, has completed, sponsored by Lallemand Health Solutions.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 144 participants
- Enrollment target
Study Summary
This Phase II study is designed to evaluate the potential effects of a novel probiotic supplement on the severity of global menopause symptoms (e.g., psychological, somatic, urogenital symptoms) and on bone health in postmenopausal women.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Probiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2019-07-29 |
| Est. Completion | 2021-04-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04001088
The ClinicalTrials.gov registry entry for NCT04001088 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lallemand Health Solutions, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04001088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04001088 about?
NCT04001088 is a clinical study titled "The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health". This Phase II study is designed to evaluate the potential effects of a novel probiotic supplement on the severity of global menopause symptoms (e.g., psychological, somatic, urogenital symptoms) and on bone health in postmenopausal women.
What is the current status of trial NCT04001088?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 144 participants. The study started on 2019-07-29. Estimated completion is 2021-04-23.
What interventions are being tested in trial NCT04001088?
The interventions under investigation include: Placebo (OTHER), Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04001088?
This trial is sponsored by Lallemand Health Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.